Literature DB >> 18394441

Relation of bone mineral density to frequency of coronary heart disease.

Raja Varma1, Wilbert S Aronow, Yana Basis, Tarundit Singh, Kumar Kalapatapu, Melvin B Weiss, Anthony L Pucillo, Craig E Monsen.   

Abstract

Coronary angiography was performed because of chest pain in 198 patients (146 women, 52 men; mean age 66 years) who had dual-energy x-ray absorptiometry scans of the spine and left hip because of suspected osteoporosis or osteopenia. Of the 198 patients, 53 (27%) had osteoporosis, 79 (40%) had osteopenia, and 66 (33%) had normal bone mineral density (BMD). Obstructive coronary artery disease with >50% narrowing of > or =1 major coronary artery was present in 40 of 53 patients (76%) with osteoporosis, in 54 of 79 patients (68%) with osteopenia, and in 31 of 66 patients (47%) with normal BMD (p <0.005 comparing osteoporosis with normal BMD, p <0.01 comparing osteopenia with normal BMD). In conclusion, in patients who undergo coronary angiography because of chest pain, patients with osteoporosis or osteopenia have a higher prevalence of obstructive coronary artery disease than those with normal BMD.

Entities:  

Mesh:

Year:  2008        PMID: 18394441     DOI: 10.1016/j.amjcard.2007.12.013

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

1.  Is reduced bone mineral density independently associated with coronary artery calcification in subjects older than 50 years?

Authors:  Kwang-Il Kim; Jung-Won Suh; Su-Yeon Choi; Hyuk-Jae Chang; Dong-Ju Choi; Cheol-Ho Kim; Byung-Hee Oh
Journal:  J Bone Miner Metab       Date:  2010-11-12       Impact factor: 2.626

2.  Panoramic images of white and black post-menopausal females evidencing carotid calcifications are at high risk of comorbid osteopenia of the femoral neck.

Authors:  A H Friedlander; T I Chang; N Aghazadehsanai; G R Berenji; N D Harada; N R Garrett
Journal:  Dentomaxillofac Radiol       Date:  2013       Impact factor: 2.419

Review 3.  Osteoporosis in chronic inflammatory disease: the role of malnutrition.

Authors:  Tiziana Montalcini; Stefano Romeo; Yvelise Ferro; Valeria Migliaccio; Carmine Gazzaruso; Arturo Pujia
Journal:  Endocrine       Date:  2012-10-09       Impact factor: 3.633

4.  The relation of low levels of bone mineral density with coronary artery calcium and mortality.

Authors:  N Ahmadi; S S Mao; F Hajsadeghi; B Arnold; S Kiramijyan; Y Gao; F Flores; S Azen; M Budoff
Journal:  Osteoporos Int       Date:  2018-04-27       Impact factor: 4.507

5.  Future of anticathepsin K drugs: dual therapy for skeletal disease and atherosclerosis?

Authors:  Izabela Podgorski
Journal:  Future Med Chem       Date:  2009-04       Impact factor: 3.808

6.  Low bone mineral density is not associated with angiographically determined coronary atherosclerosis in men.

Authors:  S Beer; C H Saely; G Hoefle; P Rein; A Vonbank; J Breuss; B Gaensbacher; A Muendlein; H Drexel
Journal:  Osteoporos Int       Date:  2009-11-21       Impact factor: 4.507

7.  Bone mineral density and coronary atherosclerosis.

Authors:  Shokoofeh Hajsadeghi; Mohamad-Ebrahim Khamseh; Bagher Larijani; Behzad Abedin; Anoushiravan Vakili-Zarch; Amir-Pasha Meysamie; Fariba Yazdanpanah
Journal:  J Saudi Heart Assoc       Date:  2011-03-14

8.  Osteoporosis, osteopenia, and atherosclerotic vascular disease.

Authors:  Wilbert S Aronow
Journal:  Arch Med Sci       Date:  2011-03-08       Impact factor: 3.318

Review 9.  (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis.

Authors:  Debby den Uyl; Mike T Nurmohamed; Lilian Hd van Tuyl; Hennie G Raterman; Willem F Lems
Journal:  Arthritis Res Ther       Date:  2011-01-17       Impact factor: 5.156

10.  Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.

Authors:  J-J Body; P Bergmann; S Boonen; J-P Devogelaer; E Gielen; S Goemaere; J-M Kaufman; S Rozenberg; J-Y Reginster
Journal:  Osteoporos Int       Date:  2012-02-04       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.